macro1 min
韩国患者赴日治疗年花1万亿韩元，癌症和糖尿病干细胞治疗受关注
发布: · 来源: mk.co.kr
一句$话总结: 据报道，韩国患者在日本医疗机构接受癌症、糖尿病相关干细胞治疗等赴日治疗，每年支出约1万亿韩元。
广告
Get notifications
据报道，韩国患者在日本接受癌症、糖尿病相关干细胞治疗等赴日治疗，每年支出约1万亿韩元。报道介绍了位于东京港区竹芝的“New Pier Takeshiba South Tower”，从羽田机场驱车约20分钟即可到达。上午9点，报道提到该楼13层的“Tokyo Cell Clinic”。其背景是韩国患者对日本开展的癌症、糖尿病干细胞治疗的关注。随着相关支出规模被称为每年1万亿韩元，海外治疗需求和费用负担一同受到关注。来源: mk.co.kr
广告
Get notifications
Partner picks
Relevant partner links for this story
A lightweight commerce block designed to add monetization without breaking reading flow.
Coupang PartnersKR conversion
Good fit for Korea-based visitors ready to buy.
View offerAliExpressBudget picks
Works well for price-sensitive gadget and desk-tool traffic.
View offerAmazon AssociatesGlobal reach
Useful for books, work tools, and international shoppers.
View offerThis module may include affiliate links that earn a commission from qualifying purchases. 매크로시그널
Sponsored
11개 언어 자동 번역
한 번 작성하면 11개 언어로 자동 노출
广告
11개 언어 자동 번역
